Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist

Islet transplantation is a feasible therapeutic alternative for metabolically labile patients with type 1 diabetes. The primary therapeutic target is stable glycemic control and prevention of complications associated with diabetes by reconstitution of endogenous insulin secretion. However, critical shortage of donor organs, gradual loss in graft function over time, and chronic need for immunosuppression limit the indication for islet transplantation to a small group of patients. Here we present a promising approach to address these limitations by utilization of a macrochamber specially engineered for islet transplantation. The s.c. implantable device allows for controlled and adequate oxygen supply and provides immunological protection of donor islets against the host immune system. The minimally invasive implantable chamber normalized blood glucose in streptozotocin-induced diabetic rodents for up to 3 mo. Sufficient graft function depended on oxygen supply. Pretreatment with the growth hormone-releasing hormone (GHRH) agonist, JI-36, significantly enhanced graft function by improving glucose tolerance and increasing β-cell insulin reserve in rats thereby allowing for a reduction of the islet mass required for metabolic control. As a result of hypervascularization of the tissue surrounding the device, no relevant delay in insulin response to glucose changes has been observed. Consequently, this system opens up a fundamental strategy for therapy of diabetes and may provide a promising avenue for future approaches to xenotransplantation.

[1]  O. Korsgren,et al.  Using HTK for prolonged pancreas preservation prior to human islet isolation. , 2012, The Journal of surgical research.

[2]  A. Shapiro.  Strategies toward single-donor islets of Langerhans transplantation , 2011, Current opinion in organ transplantation.

[3]  H. Noguchi.  Pancreas Procurement and Preservation for Islet Transplantation: Personal Considerations , 2011, Journal of transplantation.

[4]  Bernard Gallez,et al.  The impact of hyperglycemia and the presence of encapsulated islets on oxygenation within a bioartificial pancreas in the presence of mesenchymal stem cells in a diabetic Wistar rat model. , 2011, Biomaterials.

[5]  S. Bornstein,et al.  A Novel Device for Islet Transplantation Providing Immune Protection and Oxygen Supply , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[6]  T. Berney,et al.  Donor pancreata: evolving approaches to organ allocation for whole pancreas versus islet transplantation. , 2010, Transplantation.

[7]  B. Hammer,et al.  Persufflation improves pancreas preservation when compared with the two-layer method. , 2010, Transplantation proceedings.

[8]  Stefan R Bornstein,et al.  Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets , 2010, Proceedings of the National Academy of Sciences.

[9]  G. Weir,et al.  Prediction of Marginal Mass Required for Successful Islet Transplantation , 2010, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[10]  C. K. Colton,et al.  Rat islet cell aggregates are superior to islets for transplantation in microcapsules , 2010, Diabetologia.

[11]  G. Weir,et al.  Oxygen consumption and diffusion in assemblages of respiring spheres: Performance enhancement of a bioartificial pancreas , 2009 .

[12]  S. Petersenn,et al.  Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: Antiproliferative effects of peptide analogues , 2009, Proceedings of the National Academy of Sciences.

[13]  J. Bluestone,et al.  2007 Update on Allogeneic Islet Transplantation from the Collaborative Islet Transplant Registry (CITR) , 2009, Cell transplantation.

[14]  A. Werynski,et al.  Isolation, banking, encapsulation and transplantation of different types of Langerhans islets. , 2009, Polskie Archiwum Medycyny Wewnetrznej.

[15]  Seung-Hee Lee,et al.  Human β-cell Precursors Mature Into Functional Insulin-producing Cells in an Immunoisolation Device: Implications for Diabetes Cell Therapies , 2009, Transplantation.

[16]  P. Carlsson,et al.  Low Revascularization of Human Islets When Experimentally Transplanted Into the Liver , 2009, Transplantation.

[17]  Susan C. Roberts,et al.  Hydrogel‐Perfluorocarbon Composite Scaffold Promotes Oxygen Transport to Immobilized Cells , 2008, Biotechnology progress.

[18]  C. Ricordi,et al.  Allosensitization of Islet Allograft Recipients , 2007, Transplantation.

[19]  G. Weir,et al.  A stirred microchamber for oxygen consumption rate measurements with pancreatic islets , 2007, Biotechnology and bioengineering.

[20]  G. Weir,et al.  Human Islet Oxygen Consumption Rate and DNA Measurements Predict Diabetes Reversal in Nude Mice , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  Wolfgang Moritz,et al.  Superiority of Small Islets in Human Islet Transplantation , 2007, Diabetes.

[22]  C. Buchanan,et al.  Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation , 2007, Xenotransplantation.

[23]  A. Steffen,et al.  Quantification of Basal and Stimulated ROS Levels as Predictors of Islet Potency and Function , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  Marcela Brissova,et al.  Pancreatic Islet Production of Vascular Endothelial Growth Factor-A Is Essential for Islet Vascularization, Revascularization, and Function , 2006, Diabetes.

[25]  Philippe Morel,et al.  International trial of the Edmonton protocol for islet transplantation. , 2006, The New England journal of medicine.

[26]  Denis Dufrane,et al.  Six-Month Survival of Microencapsulated Pig Islets and Alginate Biocompatibility in Primates: Proof of Concept , 2006, Transplantation.

[27]  S. Beer,et al.  Photosynthetic oxygen generator for bioartificial pancreas. , 2006, Tissue engineering.

[28]  M. Hara,et al.  Liver Ischemia Contributes to Early Islet Failure Following Intraportal Transplantation: Benefits of Liver Ischemic‐Preconditioning , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  C. Colton,et al.  Tissue Engineering for Insulin Replacement in Diabetes , 2005 .

[30]  O. Källskog,et al.  Duct ligation and pancreatic islet blood flow in rats: physiological growth of islets does not affect islet blood perfusion. , 2005, European journal of endocrinology.

[31]  J. Schrezenmeir,et al.  Effect of the immunosuppressive regime of Edmonton protocol on the long-term in vitro insulin secretion from islets of two different species and age categories. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.

[32]  M. Doser,et al.  Encapsulation of Islets in Rough Surface, Hydroxymethylated Polysulfone Capillaries Stimulates VEGF Release and Promotes Vascularization after Transplantation , 2005, Cell transplantation.

[33]  S. Hughes,et al.  Hyperoxia improves the survival of intraportally transplanted syngeneic pancreatic islets , 2003, Transplantation.

[34]  A. Shapiro,et al.  Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. , 2002, Diabetes.

[35]  P. Carlsson,et al.  Glucose-induced islet blood flow increase in rats: interaction between nervous and metabolic mediators. , 2002, American journal of physiology. Endocrinology and metabolism.

[36]  P. de Vos,et al.  Encapsulation of pancreatic islets for transplantation in diabetes: the untouchable islets. , 2002, Trends in molecular medicine.

[37]  C. Rhodes,et al.  Pancreatic β-cell growth and survival – a role in obesity-linked type 2 diabetes? , 2002 .

[38]  V. Rodgers,et al.  Mathematical modeling of myoglobin facilitated transport of oxygen in devices containing myoglobin-expressing cells. , 2002, Mathematical Biosciences.

[39]  G. Weir,et al.  Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. , 2001, Diabetes.

[40]  P. Liss,et al.  Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. , 2001, Diabetes.

[41]  T. Mandrup-Poulsen.  beta-cell apoptosis: stimuli and signaling. , 2001, Diabetes.

[42]  A. Schally,et al.  Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Bonner-Weir,et al.  In Situ Electrochemical Oxygen Generation with an Immunoisolation Device , 1999, Annals of the New York Academy of Sciences.

[44]  Hua Yang,et al.  Tilapia--a source of hypoxia-resistant islet cells for encapsulation. , 1998, Cell transplantation.

[45]  A. Schally,et al.  Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Bonner-Weir,et al.  A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice. , 1995, Transplantation.

[47]  L. Jansson.  The regulation of pancreatic islet blood flow. , 1994, Diabetes/metabolism reviews.

[48]  Y. Lepage,et al.  Studies on Small (<300 μm) Microcapsules: II — Parameters Governing the Production of Alginate Beads by High Voltage Electrostatic Pulses , 1994, Cell transplantation.

[49]  R. Lanza,et al.  Relationship between insulin secretion and oxygen tension in hybrid diffusion chambers. , 1993, ASAIO journal.

[50]  C. Colton,et al.  Effect of Hypoxia on Insulin Secretion by Isolated Rat and Canine Islets of Langerhans , 1993, Diabetes.

[51]  P. Lacy,et al.  PROLONGATION OF ISLET XENOGRAFT SURVIVAL BY IN VITRO CULTURE OF RAT MEGAISLETS IN 95% O21 , 1982, Transplantation.

[52]  B. Reitz,et al.  Simplified operative method for heart and lung transplantation. , 1981, The Journal of surgical research.

[53]  N. Lifson,et al.  Blood flow to the rabbit pancreas with special reference to the islets of langerhans , 1980 .

[54]  H. Watada.  Role of VEGF-A in pancreatic beta cells. , 2010, Endocrine journal.

[55]  Amy Lewis,et al.  Chapter Twenty-Nine – Engineering Challenges in Immunobarrier Device Development , 2007 .

[56]  A. Vasconcellos,et al.  Transplantation of micro- and macroencapsulated piglet islets into mice and monkeys. , 2005, Transplantation proceedings.

[57]  E. Montanya,et al.  Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. , 2002, Diabetes.

[58]  C. Rhodes,et al.  Pancreatic beta-cell growth and survival--a role in obesity-linked type 2 diabetes? , 2002, Trends in molecular medicine.

[59]  T. Lohmann,et al.  Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunsuppressive therapy by FK506/tacrolimus. , 2000, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[60]  A. Møldrup,et al.  Beta cell proliferation and growth factors , 1999, Journal of Molecular Medicine.

[61]  R. C. Johnson,et al.  In vivo delivery of recombinant human growth hormone from genetically engineered human fibroblasts implanted within Baxter immunoisolation devices , 1999, Journal of Molecular Medicine.

[62]  N. Lifson,et al.  Blood flow to the rabbit pancreas with special reference to the islets of Langerhans. , 1980, Gastroenterology.

[63]  N. Barshes,et al.  islet transplantation: implications for intrahepatic grafts , 2022 .